Wednesday, December 11, 2019
The stock market has had an excellent year for 2019, and one sector that’s been unusually hot recently has been healthcare. Over the last two months, the healthcare stocks in the S&P 500, as a whole, have nearly doubled the return of the rest of the index. That’s impressive, and while many healthcare stocks are […]
With the near term potential of an economic recession at the front of investor’s minds, I see more and more recommendations to invest in “Dividend Aristocrat” types of stocks. These are companies that have paid growing dividends for years and give investors faith that their stock market investments will emerge relatively unscathed after the stock […]
With all the headlines about tariffs and interest rates these days, it makes sense to see a lot of trading activity going on in related sectors. That is, interest rates directly impact the financial sector; tariffs are a big deal for the basic materials and industrial sectors, etc. One sector we haven’t heard as much […]
The science of medicine, as well as pharmaceutical companies, is moving more and more toward personalized medicine. That is, specialized cell and gene therapies designed to attack a patient’s unique condition. Curing a patient of once-fatal diseases will save our healthcare system an enormous amount of money… but only over the long-term. These treatments require […]
Just last week I told you about the new version of its watch by Apple (Nasdaq: AAPL), which offers a bunch of health features, such as an EKG. The watch though is just the tip of the proverbial iceberg when it comes to how technology is changing medicine. One area that really has me excited […]
I’m a great believer in looking at areas that few on Wall Street do for growth opportunities. I like to find a major positive change happening in the global macroeconomic environment that will benefit a sector or industry and then uncover a company that should benefit from this change in the long term. I’ve recently […]
Once again, stock market jitters worldwide have emerged in August when trading desks are thinly manned with junior staff. This year, the worries emanated from the self-inflicted economic woes in Turkey brought on by its leader, President Recip Tayyip Erdogan. He thinks he knows more than markets and has taken full control of the Turkish […]
There has been no company like Amazon.com (Nasdaq: AMZN) ever with the ability to affect entire industries just by announcing its entry. The most recent example of this was in late June when Amazon announced a roughly $1 billion acquisition of PillPack, a mail-order pharmacy that packages pills into daily portions before shipping them to […]
In the midst of a much-needed turnaround and upcoming name change, one very well-known pharmaceutical company just suffered a setback on a new drug. And with an astonishing level of debt, investors might have got too carried away with the story. A simple name change won’t fix this stock.
For an investor trying to build wealth, the massive amount of news coming out of the financial media can be contradictory and confusing. Investors sometimes don’t realize that there are two sides to every stock trade. The seller doesn’t want to own the shares for a range or reasons, and the buyer does so with […]
